Oak Thistle LLC Purchases Shares of 20,927 The Cooper Companies, Inc. $COO

Key Points

• Oak Thistle LLC acquired a new stake of 20,927 shares in The Cooper Companies (NASDAQ:COO) during Q4, valued at about $1.715 million.
• Cooper Companies beat Q4 EPS expectations, reporting $1.10 versus a $1.03 consensus on $1.02 billion of revenue (up 6.2% year-over-year) and set Q2 2026 guidance at $4.580–4.660 EPS.
• Analyst sentiment is generally positive with a consensus "Moderate Buy" and a $90.79 target, amid mixed recent actions including upgrades (Barclays to $103) and downgrades (Rothschild & Co Redburn to neutral).

Oak Thistle LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 20,927 shares of the medical device company's stock, valued at approximately $1,715,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. 4WEALTH Advisors Inc. lifted its position in shares of Cooper Companies by 4.9% during the 4th quarter. 4WEALTH Advisors Inc. now owns 4,439 shares of the medical device company's stock valued at $364,000 after acquiring an additional 206 shares during the last quarter. Savvy Advisors Inc. acquired a new stake in shares of Cooper Companies during the 4th quarter valued at $205,000. First American Bank lifted its position in shares of Cooper Companies by 2.0% during the 4th quarter. First American Bank now owns 24,484 shares of the medical device company's stock valued at $2,007,000 after acquiring an additional 473 shares during the last quarter. Cromwell Holdings LLC lifted its position in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company's stock valued at $40,000 after acquiring an additional 273 shares during the last quarter. Finally, Tritonpoint Wealth LLC acquired a new stake in shares of Cooper Companies during the 4th quarter valued at $203,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Price Performance

COO opened at $71.73 on Thursday. The stock has a fifty day moving average of $77.07 and a 200-day moving average of $76.38. The firm has a market capitalization of $14.00 billion, a P/E ratio of 35.51, a PEG ratio of 1.81 and a beta of 1.07. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $89.83. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.03 by $0.07. The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company's revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Ratings Changes

COO has been the subject of a number of recent research reports. Wall Street Zen upgraded Cooper Companies from a "hold" rating to a "buy" rating in a research report on Saturday, February 28th. Barclays increased their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, March 6th. Rothschild & Co Redburn downgraded Cooper Companies from a "buy" rating to a "neutral" rating and set a $85.00 price objective for the company. in a research report on Wednesday, March 4th. Needham & Company LLC increased their price objective on Cooper Companies from $99.00 to $101.00 and gave the company a "buy" rating in a research report on Friday, March 6th. Finally, Citigroup cut their price objective on Cooper Companies from $88.00 to $87.00 and set a "neutral" rating for the company in a research report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus target price of $90.79.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.